Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 23;9(9):CD013169.
doi: 10.1002/14651858.CD013169.pub2.

Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea

Frederico T Barbosa  1 , Michele P Silva  2   3 , Luís Eduardo S Fontes  3   4 , Daniela V Pachito  5 , Tamara Melnik  6 , Rachel Riera  3   7   8
Affiliations

Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea

Frederico T Barbosa et al. Cochrane Database Syst Rev. .

Abstract

Background: Obstructive sleep apnoea syndrome (OSAS) is associated with several chronic diseases, including erectile dysfunction (ED). The association of OSAS and ED is far more common than might be found by chance; the treatment of OSAS with non-invasive positive airway pressure therapy is associated with improvement of respiratory symptoms, and may contribute to the improvement of associated conditions, such as ED.

Objectives: To assess the effectiveness and acceptability of non-invasive positive airway pressure therapy for improving erectile dysfunction in OSAS.

Search methods: We identified studies from the Cochrane Airways Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, AMED EBSCO, and LILACS, the US National Institutes of Health ongoing trials register ClinicalTrials.gov, and the World Health Organisation international clinical trials registry platform to 14 June 2021, with no restriction on date, language, or status of publication. We checked the reference lists of all primary studies, and review articles for additional references, and relevant manufacturers' websites for study information. We also searched specific conference proceedings for the British Association of Urological Surgeons; the European Association of Urology; and the American Urological Association to 14 June 2021.

Selection criteria: We considered randomised controlled trials (RCTs) with a parallel or cross-over design, or cluster-RCTs, which included men aged 18 years or older, with OSAS and ED. We considered RCTs comparing any non-invasive positive airway pressure therapy (such as continuous positive airways pressure (CPAP), bilevel positive airway pressure (BiPAP), variable positive airway pressure (VPAP), or similar devices) versus sham, no treatment, waiting list, or pharmacological treatment for ED. The primary outcomes were remission of ED and serious adverse events; secondary outcome were sex-related quality of life, health-related quality of life, and minor adverse events.

Data collection and analysis: Two review authors independently conducted study selection, data extraction, and risk of bias assessment. A third review author solved any disagreement. We used the Cochrane RoB 1 tool to assess the risk of bias of the included RCTs. We used the GRADE approach to assess the certainty of the body of evidence. To measure the treatment effect on dichotomous outcomes, we used the risk ratio (RR); for continuous outcomes, we used the mean difference (MD). We calculated 95% confidence intervals (CI) for these measures. When possible (data availability and homogeneous studies), we used a random-effect model to pool data with a meta-analysis.

Main results: We included six RCTs (all assessing CPAP as the non-invasive positive airway pressure therapy device), with a total of 315 men with OSAS and ED. All RCTs presented some important risk of bias related to selection, performance, assessment, or reporting bias. None of included RCTs assessed the ED remission rate, and we used the provided ED mean scores as a proxy. CPAP versus no CPAP There is uncertainty about the effect of CPAP on mean ED scores after 4 weeks, using the International index of erectile function (IIEF-5, higher = better; MD 7.50, 95% CI 4.05 to 10.95; 1 RCT; 27 participants; very low-certainty evidence), and after 12 weeks (IIEF-ED, ED domain; MD 2.50, 95% CI -1.10 to 6.10; 1 RCT; 57 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision). There is uncertainty about the effect of CPAP on sex-related quality of life after 12 weeks, using the Self-esteem and relationship test (SEAR, higher = better; MD 1.00, 95% CI -8.09 to 10.09; 1 RCT; 57 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision); no serious adverse events were reported after 4 weeks (1 RCT; 27 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision). CPAP versus sham CPAP One RCT assessed this comparison (61 participants), but we were unable to extract outcomes for this comparison due to the factorial design and reporting of this trial. CPAP versus sildenafil (phosphodiesterase type 5 inhibitors) Sildenafil may slightly improve erectile function at 12 weeks when compared to CPAP, measured with the IIEF-ED (MD -4.78, 95% CI -6.98 to -2.58; 3 RCTs; 152 participants; I² = 59%; low-certainty evidence, downgraded due to methodological limitations). There is uncertainty about the effect of CPAP on sex-related quality of life after 12 weeks, measured with the Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire (EDITS, higher = better; MD -1.24, 95% CI -1.80 to -0.67; 2 RCTs; 122 participants; I² = 0%; very low-certainty evidence, downgraded due to methodological limitations). No serious adverse events were reported for either group (2 RCTs; 70 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision). There is uncertainty about the effects of CPAP when compared to sildenafil for the incidence of minor adverse events (RR 1.33, 95% CI 0.34 to 5.21; 1 RCT; 40 participants; very low-certainty evidence, downgraded due to methodological limitations and imprecision). The confidence interval was wide and neither a significant increase nor reduction in the risk of minor adverse events can be ruled out with the use of CPAP (4/20 men complained of nasal dryness in the CPAP group, and 3/20 men complained of transient flushing and mild headache in the sildenafil group).

Authors' conclusions: When compared with no CPAP, we are uncertain about the effectiveness and acceptability of CPAP for improving erectile dysfunction in men with obstructive sleep apnoea. When compared with sildenafil, there is some evidence that sildenafil may slightly improve erectile function at 12 weeks.

PubMed Disclaimer

Conflict of interest statement

FT Barbosa: none known

MP Silva: none known

LES Fontes: none known

DV Pachito: received funds from ResMed Brazil for consultancy activities in the field of Health Economics. ResMed manufactures CPAP and ventilator machines and accessories.

T Melnik: none known

R Riera: none known

Figures

1
1
PRISMA study flow diagram
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study
3
3
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies
4
4
Forest plot of comparison: 1 CPAP versus phosphodiesterase type 5 inhibitors, outcome: 1.1 Erectile dysfunction
5
5
Forest plot of comparison: 1 CPAP versus phosphodiesterase type 5 inhibitors, outcome: 1.2 Sexual‐related quality of life (EDITS Q1).
1.1
1.1. Analysis
Comparison 1: CPAP versus no CPAP, Outcome 1: Erectile dysfunction
1.2
1.2. Analysis
Comparison 1: CPAP versus no CPAP, Outcome 2: Sex‐related quality of life
2.1
2.1. Analysis
Comparison 2: CPAP versus phosphodiesterase type 5 (PDE5) inhibitors, Outcome 1: Erectile dysfunction
2.2
2.2. Analysis
Comparison 2: CPAP versus phosphodiesterase type 5 (PDE5) inhibitors, Outcome 2: Sex‐related quality of life (EDIT Q1)
2.3
2.3. Analysis
Comparison 2: CPAP versus phosphodiesterase type 5 (PDE5) inhibitors, Outcome 3: Minor adverse events
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Li 2004 {published data only}
    1. Li F, Feng Q, Zhang X, Liu Q. Treatment for erectile dysfunction patients with obstructive sleep apnea syndrome by nasal continual positive airway pressure. National Journal of Andrology 2004;10(5):355-7. [PMID: ] - PubMed
Melehan 2018 {published data only}
    1. Melehan K, Hoyos C, Yee B, O'Meagher S, Hamilton G, Mclachlan R, et al. CPAP use improves sexual function in men with OSA and erectile dysfunction (ED): a randomised controlled study. Sleep and Biological Rhythms 2014;12(Suppl 1):2.
    1. Melehan K, Hoyos CM, Hamilton GS, Wong KK, Yee BJ, Mclachlan R, et al. CPAP use improves sexual function in men with OSA and erectile dysfunction (ED): a randomised controlled study. Journal of Sleep Research 2014;23:68.
    1. Melehan KL, Hoyos CM, Hamilton GS, Wong KK, Yee BJ, McLachlan RI, et al. Adherent CPAP improves erectile and sexual function and quality of life in men with OSA and erectile dysfunction (ED): a randomised sham controlled study. Endocrine Reviews 2014;35(3):341-55.
    1. Melehan KL, Hoyos CM, Hamilton GS, Wong KK, Yee BJ, McLachlan RI, et al. CPAP use improves sexual function in men with OSA and erectile dysfunction: a randomised controlled study. Associated Professional Sleep Societies 2014;37:A125.
    1. Melehan KL, Hoyos CM, Hamilton GS, Wong KK, Yee BJ, McLachlan RI, et al. Randomized trial of CPAP and vardenafil on erectile and arterial function in men with obstructive sleep apnea and erectile dysfunction. Journal of Clinical Endocrinology and Metabolism 2018;103(4):1601-11. [PMID: ] - PMC - PubMed
Pascual 2018 {published data only}
    1. Pascual M, Batlle J, Barbe F, Castro-Grattoni AL, Auguet JM, Pascual L, et al. Erectile dysfunction in obstructive sleep apnea patients: a randomized trial on the effects of continuous positive airway pressure (CPAP). PloS One 2018;13(8):e0201930. [PMID: ] - PMC - PubMed
Pastore 2014 {published data only}
    1. Pastore AL, Palleschi G, Ripoli A, Silvestri L, Maggioni C, Pagliuca G, et al. Severe obstructive sleep apnoea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil vs. nasal continuous positive airway pressure. International Journal of Clinical Practice 2014;68(8):995-1000. [PMID: ] - PubMed
    1. Pastore AL, Palleschi G, Silvestri L, Gallo A, Pagliuca G, Benedetti FN, et al. Severe obstructive sleep apnea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil versus nasal continuous positive airway pressure. Journal of Sexual Medicine 2015;12:193. - PubMed
    1. Pastore AL, Palleschi G, Silvestri L, Gallo A, Pagliuca G, Nobili Benedetti F, et al. Severe obstructive sleep apnea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil versus nasal continuous positive airway pressure. Journal of Sexual Medicine 2015;12:193. - PubMed
    1. Pastore AL, Palleschi G, Silvestri L, Zucchi A, Costantini E, Carbone A. Severe obstructive sleep apnoea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil vs. nasal continuous positive airway pressure. Journal of Urology 2015;193:906. - PubMed
    1. Pastore AL, Palleschi G, Silvestri L, Zucchi A, Costantini E, Carbone A. Severe obstructive sleep apnoea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil vs. nasal continuous positive airway pressure. Journal of Urology 2015;193:906. - PubMed
Perimenis 2004 {published data only}
    1. Perimenis P, Karkoulias K, Markou S, Gyftopoulos K, Athanasopoulos A, Barbalias G, et al. Erectile dysfunction in men with obstructive sleep apnea syndrome: a randomized study of the efficacy of sildenafil and continuous positive airway pressure. International Journal of Impotence Research 2004;16:256-60. - PubMed
Perimenis 2007 {published data only}
    1. Perimenis P, Karkoulias K, Konstantinopoulos A, Perimeni PP, Katsenis G, Athanasopoulos A, et al. Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a comparative study of their efficacy and safety and the patient's satisfaction with treatment. Asian Journal of Andrology 2007;9(2):259-64. [PMID: ] - PubMed

References to studies excluded from this review

Hoekema 2007 {published data only}
    1. Hoekema A, Stel AL, Stegenga B, Hoeven JH, Wijkstra PJ, Driel MF, et al. Sexual function and obstructive sleep apnea-hypopnea: a randomized clinical trial evaluating the effects of oral-appliance and continuous positive airway pressure therapy. Journal of Sexual Medicine 2007;4(4 Pt 2):1153-62. [PMID: ] - PubMed
Karkoulias 2006 {published data only}
    1. Perimenis P, Karkoulias K, Markou S, GyftopoulosK, Kartsanis G, Athanasopoulos A, et al. A crossover study of the efficacy of sildenafil in the treatment of erectile dysfunction (ED) in men with obstructive sleep apnea syndrome (OSAS) treated with continuous positive airway pressure (CPAP). European Respiratory Journal 2006;28:42.
Perimenis 2007a {published data only}
    1. Perimenis P, Konstantinopoulos A, Karkoulias K, Markou S, Perimeni P, Spyropoulos K. Sildenafil combined with continuous positive airway pressure for treatment of erectile dysfunction in men with obstructive sleep apnea. International Urology and Nephrology 2007;39(2):547-52. [PMID: ] - PubMed
Taskin 2010 {published data only}
    1. Taskin U, Yigit O, Acioglu E, Aricigil M, Toktas G, Guzelhan Y. Erectile dysfunction in severe sleep apnea patients and response to CPAP. International Journal of Impotence Research 2010;22(2):134-9. [PMID: ] - PubMed

Additional references

Abraham 2009
    1. Abraham L, Symonds T, May K, Althof SE, Hallam-Jones R, Rosen RC. Psychometric validation of gender nonspecific sexual confidence and sexual relationship scales in men and women. Journal of Sexual Medicine 2009;6(8):2244-54. [PMID: ] - PubMed
Alonso‐Fernandez 2009
    1. Alonso-Fernandez A, Garcia-Rio F, Arias MA, Hernanz A, la Pena M, Pierola J, et al. Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trial. Thorax 2009;64(7):581-6. - PubMed
Althof 1999
    1. Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999;53(4):793-9. [PMID: ] - PubMed
Althof 2002
    1. Althof SE. Quality of life and erectile dysfunction. Urology 2002;59(6):803-10. - PubMed
American Academy of Sleep Medicine 2014
    1. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd edition. Darien (USA): American Academy of Sleep Medicine, 2014. - PMC - PubMed
Andersen 2010
    1. Andersen ML, Santos-Silva R, Bittencourt LR, Tufik S. Prevalence of erectile dysfunction complaints associated with sleep disturbances in São Paulo, Brazil: a population-based survey. Sleep Medicine 2010;11(10):1019-24. [PMID: ] - PubMed
Antic 2011
    1. Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, et al. The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 2011;34(1):111-9. [PMID: ] - PMC - PubMed
APA 2013
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 5th edition. Washington (DC): American Psychiatric Association Publishing, 2013.
Arnardottir 2009
    1. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009;32(4):447-70. - PMC - PubMed
Baguet 2012
    1. Baguet J-P, Barone-Rochette G, Tamisier R, Levy P, Pépin J-L. Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nature Reviews Cardiology 2012;9(12):679-88. - PubMed
Budweiser 2013
    1. Budweiser S, Luigart R, Jörres RA, Kollert F, Kleemann Y, Wieland WF, et al. Long-term changes of sexual function in men with obstructive sleep apnea after initiation of continuous positive airway pressure. Journal of Sexual Medicine 2013;10:524-31. - PubMed
Cappelleri 2004
    1. Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S. Development and validation of the self-esteem and relationship (SEAR) questionnaire in erectile dysfunction. International Journal of Impotence Research 2004;16:30-2. [PMID: ] - PubMed
Cappelleri 2007
    1. Cappelleri JC, Althof SE, O’Leary MP, Glina S, King R, Stecher VJ, et al. Clinically meaningful improvement on the self-esteem and relationship questionnaire in men with erectile dysfunction. Quality of Life Research 2007;16:1203-10. [DOI: 10.1007/s11136-007-9232-2] - DOI - PubMed
Cappelleri 2018
    1. Cappelleri JC, Tseng LJ, Stecher VJ, Althof SE. Clinically important difference on the erectile dysfunction inventory of treatment satisfaction questionnaire in patients with erectile dysfunction. International Journal of Clinical Practice 2018;72(4):e13073. [DOI: ] - PubMed
Chowdhury 2010
    1. Chowdhury M, Adams S, Whellan DJ. Sleep-disordered breathing and heart failure: focus on obstructive sleep apnea and treatment with continuous positive airway pressure. Journal of Cardiac Failure 2010;16(2):164-74. - PubMed
Dong 2010
    1. Li X, Dong Z, Wan Y, Wang Z. Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a meta-analysis. Aging Male 2010;13(2):82-6. - PubMed
Droller 1993
    1. Droller MJ, Anderson JR, Beck JC, Bremner WJ, Evans K, Gray M, et al, Consensus Development Panel. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270(1):83-90. [PMID: ] - PubMed
Dyken 2009
    1. Dyken ME, Im KB. Obstructive sleep apnea and stroke. Chest 2009;136(6):1668-77. - PubMed
Eckert 2008
    1. Eckert DJ, Malhotra A. Pathophysiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society 2008;5(2):144-53. - PMC - PubMed
Ende 1990
    1. Walker HK, Hall WD, Hurst JW, editors. Organic impotence. In: Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths, 1990. [PMID: ] - PubMed
Epstein 2009
    1. Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Journal of Clinical Sleep Medicine 2009;5(3):263-76. - PMC - PubMed
Feldman 1994
    1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Ageing Study. Journal of Urology 1994;151(1):54-61. [PMID: ] - PubMed
Galvez‐Ruiz 2013
    1. Galvez-Ruiz A, Arishi N. Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases. Saudi Journal of Ophthalmology 2013;27(4):241-6. - PMC - PubMed
Giles 2006
    1. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD001106. [DOI: 10.1002/14651858.CD001106.pub3] - DOI - PubMed
Goldstein 2016
    1. Goldstein I, Tseng LJ, Creanga D, Stecher V, Kaminetsky JC. Efficacy and safety of sildenafil by age in men with erectile dysfunction. Journal of Sexual Medicine 2016;13:852-9. - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version (accessed prior to July 2021). Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
Gunnarsson 2014
    1. Gunnarsson SI, Peppard PE, Korcarz CE, Barnet JH, Aeschlimann SE, Hagen EW, et al. Obstructive sleep apnoea is associated with future subclinical carotid artery disease thirteen-year follow-up from the Wisconsin sleep cohort. Arteriosclerosis, Thrombosis, and Vascular Biology 2014;34(10):2338-42. - PMC - PubMed
Higgins 2020
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook.
Holden 2005
    1. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 2005;366(9481):218-24. - PubMed
Hoyos 2015
    1. Hoyos CM, Melehan KL, Phillips CL, Grunstein RR, Liu PY. To ED or not to ED — is erectile dysfunction in obstructive sleep apnea related to endothelial dysfunction? Sleep Medicine Reviews 2015;20:5-14. - PubMed
Jeon 2015
    1. Jeon YJ, Yoon DW, Han D, Won T-B, Kim D-Y, Shin H-W. Low quality of life and depressive symptoms as an independent risk factor for erectile dysfunction in patients with obstructive sleep apnea. Journal of Sexual Medicine 2015;12(11):2168-77. - PubMed
Jonas 2017
    1. Jonas DE, Amick HR, Feltner C, Weber RP, Arvanitis M, Stine A, et al. Screening for obstructive sleep apnea in adults: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2017;317(4):415-33. [PMID: ] - PubMed
Jordan 2014
    1. Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383(9918):736-47. [PMID: ] - PMC - PubMed
Khafagy 2012
    1. Khafagy AH, Khafagy AH. Treatment of obstructive sleep apnoea as a therapeutic modality for associated erectile dysfunction. International Journal of Clinical Practice 2012;66(12):1204-8. [PMID: ] - PubMed
Konecny 2014
    1. Konecny T, Kara T, Somers VK. Obstructive sleep apnea and hypertension — an update. Hypertension 2014;63(2):203-9. - PMC - PubMed
Li 2019
    1. Li Z, Fang Z, Xing N, Zhu S, Fan Y. The effect of CPAP and PDE5i on erectile function in men with obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis. Sleep Medicine Reviews 2019;48:101217. [PMID: ] - PubMed
Luboshitzky 2002
    1. Luboshitzky R. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. Journal of Clinical Endocrinology and Metabolism 2002;87(7):3394-8. - PubMed
Lue 2000
    1. Lue TF. Erectile dysfunction. New England Journal of Medicine 2000;342:1802-13. - PubMed
Marshall 2008
    1. Marshall NS, Wong KKH, Liu PY, Cullen SRJ, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008;31(8):1079-85. - PMC - PubMed
McDaid 2009
    1. McDaid C, Griffin S, Weatherly H, Dure K, Burgt M, Hout S, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technology Assessment 2009;13(4):iii-iv, xi-xiv, 1-119, 143-274. - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097] - DOI - PMC - PubMed
Montague 2005
    1. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, et al. The management of erectile dysfunction. American Urological Association 2005;1:174. - PubMed
Muneer 2014
    1. Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ 2014;348:g129. [PMID: ] - PubMed
NIH Consens Statement Online 1992
    1. Droller MJ, Anderson JR, Beck JC, Bremner WJ, Evans K, Gray M, et al. Impotence. NIH Consensus Statement Online. consensus.nih.gov/1992/1992impotence091html.htm (accessed 10 September 2021).
Peppard 2013
    1. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. American Journal of Epidemiology 2013;177(9):1006-14. - PMC - PubMed
Qiu 2017
    1. Qiu ZH, Luo YM, McEvoy RD. The Sleep Apnea Cardiovascular Endpoints (SAVE) study: implications for health services and sleep research in China and elsewhere. Journal of Thoracic Disease 2017;9(8):2217-20. [PMID: ] - PMC - PubMed
RevMan Web 2020 [Computer program]
    1. Review Manager Web (RevMan Web). Version 1.22.0. The Cochrane Collaboration, 2020. available at revman.cochrane.org.
Rosen 1997
    1. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index Of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49(6):822-30. [PMID: ] - PubMed
Rosen 1999
    1. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 1999;11(6):319-26. [PMID: ] - PubMed
Rosen 2004
    1. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Current Medical Research and Opinion 2004;20(5):607-17. - PubMed
Rosen 2011
    1. Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function Scale. European Urology 2011;60:1010-6. [PMID: ] - PubMed
Rotenberg 2016
    1. Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. Journal of Otolaryngology 2016;45(1):1-9. - PMC - PubMed
Santos 2012
    1. Santos T, Drummond M, Botelho F. Erectile dysfunction and obstructive sleep apnea syndrome. Portuguese Journal of Pulmonology 2012;18(2):64-71. - PubMed
Sawyer 2011
    1. Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Medicine Reviews 2011;15(6):343-56. [PMID: ] - PMC - PubMed
Schwarz 2015
    1. Schwarz EI, Puhan MA, Schlatzer C, Stradling JR, Kohler M. Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: a systematic review and meta-analysis. Respirology 2015;20(6):889-95. - PubMed
Seftel 2002
    1. Seftel AD, Strohl KP, Loye TL, Bayard D, Kress J, Netzer NC. Erectile dysfunction and symptoms of sleep disorders. Sleep 2002;25(6):643-7. - PubMed
Shamloul 2013
    1. Shamloul R, Ghanem H. Erectile dysfunction. Lancet 2013;381(9861):153-65. [PMID: ] - PubMed
Shin 2008
    1. Shin HW, Rha YC, Han DH, Chung S, Yoon IY, Rhee CS, et al. Erectile dysfunction and disease-specific quality of life in patients with obstructive sleep apnea. International Journal of Impotence Research 2008;20(6):549-53. - PubMed
Somers 1995
    1. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. Journal of Clinical Investigation 1995;96(4):1897-904. [PMID: ] - PMC - PubMed
Vahia 2013
    1. Vahia VN. Diagnostic and statistical manual of mental disorders 5: a quick glance. Indian Journal of Psychiatry 2013;55(3):220–3. - PMC - PubMed
Ware 2000
    1. Ware JE Jr. SF-36 Health Survey Update. Spine 2000;25(24):3130-9. - PubMed
Weaver 2007
    1. Weaver TE. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30(6):711-9. - PMC - PubMed
WHO 2010
    1. World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems (ICD-10). www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf (accessed prior to 31 August 2021).
Wolf 2007
    1. Wolf J, Lewicka J, Narkiewicz K. Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 2007;17(3):233-40. [PMID: ] - PubMed
Wolfe 1994
    1. Wolfe F. Data collection and utilization: a methodology for clinical practice and clinical research. In: Wolfe F, Pincus T, Dekker M, editor(s). Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome and Treatment. 1994: 463-514. www.niehs.nih.gov/research/resources/assets/docs/haq_instructions_508.pdf.
Xu 2015
    1. Xu H, Wang Y, Guan J, Yi H, Yin S. Effect of CPAP on endothelial function in subjects with obstructive sleep apnea: a meta-analysis. Respiratory Care 2015;60(5):749-55. [PMID: ] - PubMed
Young 2008
    1. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31(8):1071-8. - PMC - PubMed
Zimmerman 2006
    1. Zimmerman ME, Arnedt JT, Stanchina M, Millman RP, Aloia MS. Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea. Chest 2006;130(6):1772-8. [PMID: ] - PubMed

References to other published versions of this review

Silva 2018
    1. Silva MP, Fontes LES, Pachito DV, Melnik T, Riera R. Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No: CD013169. [DOI: 10.1002/14651858.CD013169] [CD013169] - DOI - PMC - PubMed

Publication types